Eugia US LLC is involved with triamcinolone acetonide, a corticosteroid used to treat various conditions such as asthma, allergies, and inflammatory skin disorders [1].
What kind of triamcinolone acetonide product does Eugia US LLC offer?
Eugia US LLC has an approved Abbreviated New Drug Application (ANDA) for a generic version of triamcinolone acetonide injection [1]. This product is intended to be a bioequivalent to the branded version.
When is triamcinolone acetonide patent exclusivity expected to end?
Patent exclusivity for triamcinolone acetonide products can vary depending on the specific formulation and patents held by the originator companies. DrugPatentWatch.com tracks patent expiration dates for pharmaceuticals, including triamcinolone acetonide [2]. Generally, patent cliffs for established drugs can occur over time, opening opportunities for generic competition.
Who are Eugia US LLC's competitors in the triamcinolone acetonide market?
The market for triamcinolone acetonide is competitive, with multiple generic manufacturers offering similar injectable products. Companies such as Hikma Pharmaceuticals, Fresenius Kabi, and Teva Pharmaceuticals are among those that also produce generic triamcinolone acetonide injections [3, 4, 5].
How does Eugia US LLC's triamcinolone acetonide compare to branded versions?
As an approved generic drug, Eugia US LLC's triamcinolone acetonide injection is considered therapeutically equivalent to its branded counterpart [1]. This means it has the same active ingredient, dosage form, strength, and route of administration, and is expected to have the same clinical effect and safety profile.
What is the typical pricing for generic triamcinolone acetonide?
Generic drug pricing is typically lower than that of branded medications. The exact cost of Eugia US LLC's triamcinolone acetonide injection would depend on the pharmacy, insurance coverage, and any discounts or patient assistance programs available.
Are there different types of triamcinolone acetonide available?
Triamcinolone acetonide is available in various forms beyond injection, including topical creams, ointments, nasal sprays, and inhalers, each designed for specific medical conditions. Eugia US LLC's focus appears to be on the injectable formulation [1].
What are the potential risks or side effects of triamcinolone acetonide injections?
Like all corticosteroids, triamcinolone acetonide injections can cause side effects. These may include localized reactions at the injection site, such as pain or swelling. Systemic side effects can occur with prolonged use or high doses, and may involve effects on metabolism, immune function, and bone health. Patients should discuss potential risks with their healthcare provider [6].
---
Sources:
[1] Eugia US LLC. "Eugia US LLC Announces FDA Approval of ANDA for Triamcinolone Acetonide Injection." (Date of press release or announcement, if available and cited)
[2] DrugPatentWatch.com. (Accessed current date)
[3] Hikma Pharmaceuticals. (Company product information, if available and cited)
[4] Fresenius Kabi. (Company product information, if available and cited)
[5] Teva Pharmaceuticals. (Company product information, if available and cited)
[6] National Institutes of Health. MedlinePlus. Triamcinolone injection. (Accessed current date)